AMANDA DAWSON: Open Payments
NPI 1508329871 · STERLING, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 35 payments from 15 companies in 2025. Trend: 2023 $148 · 2024 $918 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $190 |
| Corcept Therapeutics | 4 | $171 |
| Gilead Sciences, Inc. | 3 | $57 |
| Lilly USA, LLC | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Janssen Biotech, Inc. | 2 | $38 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Daiichi Sankyo Inc. | 1 | $28 |
Products named: Korlym, VRAYLAR, SKYRIZI, QULIPTA, AUSTEDO XR, Kerendia, TREMFYA, INJECTAFER.
Industry payments across IL — which companies pay providers there.
